30 Participants Needed

Strength Training for Muscle Mass in GLP-1 Users

(STRONG-GLP Trial)

KD
EM
Overseen ByElaina Marinik
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Virginia Polytechnic Institute and State University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

GLP-1 medication is being prescribed for weight loss. However, GLP-1 medication may adversely affect muscle mass and muscle function. Moreover, any loss of muscle mass or muscle function with GLP-1 treatment may impair balance and increase fall risk. This is a particular concern among older adults already susceptible to the common muscle strength and muscle function loss with age, yet there is little evidence among this population. This study will address a gap in knowledge regarding the effects of GLP-1 treatment on muscle mass, muscle function, and balance/fall risk among adults age 50 and older.

Who Is on the Research Team?

KD

Kevin Davy

Principal Investigator

Virginia Polytechnic Institute and State University

Are You a Good Fit for This Trial?

This trial is for adults aged 50 and older who weigh less than 300 pounds, have been taking GLP-1 medication (Weygovy or Zepbound) for a month or less, and pass a health and exercise readiness screening. It's focused on those concerned about muscle mass and function as they age.

Inclusion Criteria

I have been on GLP-1 medication (Weygovy or Zepbound) for a month or less.
I weigh less than 300 pounds.
I passed a health and fitness check for starting a new exercise program.
See 1 more

What Are the Treatments Tested in This Trial?

Interventions

  • GLP-1 Agonist
  • Strength Training

Trial Overview

The study examines how strength training affects muscle in people using GLP-1 medications for weight loss. Participants will either wait before starting strength training or begin it immediately to see the impact on muscle mass, function, and balance.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Group I: Waitlisted controlExperimental Treatment1 Intervention
Group II: Strenth TrainingExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Virginia Polytechnic Institute and State University

Lead Sponsor

Trials
162
Recruited
26,900+